UK and Australia push risk‑based breast cancer screening reforms

A new risk assessment system called Boadicea, developed by the University of Cambridge and funded by Cancer Research UK, found that current NICE guidelines in England miss up to 95% of women under 50 who will develop breast cancer within ten years. The tool, which combines family history, lifestyle, reproductive history and genetic information, identified eight times more high‑risk women than the existing criteria, prompting calls for a review of the screening guidelines.

Australia’s federal, state and territory governments have endorsed a national strategic framework for BreastScreen Australia that will replace the one‑size‑fits‑all, age‑based model with a two‑tiered, risk‑based approach. The plan calls for consistent risk assessment pathways that consider factors such as breast density, family history and lifestyle, and will incorporate newer technologies including contrast‑based imaging and AI‑driven mammogram analysis. Experts say the risk‑stratified system could detect cancers earlier, reduce treatment intensity and improve survival for women aged 40 and above.